Image Stream Medical Inc.
Entegrion landed a $43.7 million dollar contract with the Dept. of Defense for its Resusix proprietary dehydrated pathogen-inactivated human plasma.
Resusix holds promise as a substitute for fresh frozen plasma in certain situations. The Defense Dept. contract will fund Resusix’s development through Phase III clinical trials and biological license application.
Bridge Bank Provides $2.5 Million Line of Credit to Image Stream Medical, Inc.
SAN JOSE, CA–(Marketwire – Oct 3, 2011) – Bridge Capital Holdings (NASDAQ: BBNK), whose subsidiary is Bridge Bank, National Association, a full service professional business bank headquartered in Silicon Valley, announced today its funding of a $2.5 million line of credit for Image Stream Medical, Inc.
“Bridge Bank is committed to partnering with innovative and growing companies across the technology sector,” said Dick Sweeney, northeast market manager for Bridge Bank’s Technology Division. “We are pleased to be partnering with Image Stream Medical, whose technology is improving the quality and efficiency of medical procedures, to provide them with capital to fuel their next stage of growth.”
CardioDx Inc. raised $57.5 million from equity and options investments, according to its latest filing with the Securities & Exchange Commission.
The Palo Alto, Calif.-based genomics firm is developing tests based on gene expression analysis to measure patients’ risk for cardiovascular diseases.
The new financing, which is part of the $78.3 million the company is trying to raise, was supported by 17 unnamed investors, according to the SEC filing.